Paparella M - Search Results

1

Renal transplant recipients and chronic liver disease: statistical evaluation of predisposing factors.

Aroldi A, Tarantino A, Montagnino G, Paparella M, Cesana B, Rumi MG, Ponticelli C. Aroldi A, et al. Among authors: paparella m. Nephron. 1992;61(3):290-2. doi: 10.1159/000186908. Nephron. 1992. PMID: 1501727

2

How to manage the dialysis patient with chronic viral hepatitis who is considered for renal transplantation.

Paparella M, Tarantino A, Ponticelli C. Paparella M, et al. Nephrol Dial Transplant. 1996 Nov;11(11):2122-4. doi: 10.1093/oxfordjournals.ndt.a027122. Nephrol Dial Transplant. 1996. PMID: 8941564 Review. No abstract available.

3

Symptomatic accidental introduction of disinfectant electrolytic chloroxidizer solution into the peritoneal cavity of CAPD patients. Incidence and long-term effects on ultrafiltration.

De Vecchi AF, Castelnovo C, Scalamogna A, Paparella M. De Vecchi AF, et al. Among authors: paparella m. Clin Nephrol. 1992 Apr;37(4):204-8. Clin Nephrol. 1992. PMID: 1316248

4

Effect of simvastatin in CAPD patients with hypercholesterolemia.

De Vecchi A, Scalamogna A, Paparella M, Colombini M, Rovellini A, Pini C, Castelnovo C. De Vecchi A, et al. Among authors: paparella m. Adv Perit Dial. 1992;8:331-3. Adv Perit Dial. 1992. PMID: 1361817

5

[Microscopic examination of the urine. New detection using an old method].

Fogazzi GB, Passerini P, Paparella M. Fogazzi GB, et al. Among authors: paparella m. Dtsch Med Wochenschr. 1991 Nov 2;116(44):1677-81. doi: 10.1055/s-2008-1063803. Dtsch Med Wochenschr. 1991. PMID: 1935646 German. No abstract available.

6

Risk factors and action thresholds for the novel coronavirus pandemic. Insights from the Italian Society of Nephrology COVID-19 Survey.

Nordio M, Reboldi G, Di Napoli A, Quintaliani G, Alberici F, Postorino M, Aucella F, Messa P, Brunori G; Italian Society of Nephrology COVID-19 Research Group. Nordio M, et al. J Nephrol. 2021 Apr;34(2):325-335. doi: 10.1007/s40620-020-00946-3. Epub 2021 Jan 2. J Nephrol. 2021. PMID: 33387336 Free PMC article.

7

Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis.

Bazzi C, Petrini C, Rizza V, Arrigo G, Napodano P, Paparella M, D'Amico G. Bazzi C, et al. Among authors: paparella m. Nephrol Dial Transplant. 2002 Nov;17(11):1890-6. doi: 10.1093/ndt/17.11.1890. Nephrol Dial Transplant. 2002. PMID: 12401843

8

Stenting of renal artery stenosis: is it beneficial in chronic renal failure?

Rivolta R, Bazzi C, Stradiotti P, Paparella M. Rivolta R, et al. Among authors: paparella m. J Nephrol. 2005 Nov-Dec;18(6):749-54. J Nephrol. 2005. PMID: 16358234

9

What every doctor should know about drug safety in patients with chronic kidney disease.

Paparella M, Martina V, Rizzo MA, Gallieni M. Paparella M, et al. Contrib Nephrol. 2015;184:24-50. doi: 10.1159/000365821. Epub 2015 Feb 9. Contrib Nephrol. 2015. PMID: 25676290 Free article.

10

Fractional urinary excretion of IgG is the most powerful predictor of renoprotection by ACE inhibitors in IgA nephropathy.

Bazzi C, Rizza V, Paparella M, Casellato D, Napodano P, Olivieri G, D'Amico G. Bazzi C, et al. Among authors: paparella m. J Nephrol. 2009 May-Jun;22(3):387-96. J Nephrol. 2009. PMID: 19557716

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

513 results

Search Page

Filters